Skip to main content

Table 2 (Abstract A18). PRO scores of the BECOME study population set for Part 2 by PPTF and MMD

From: 13th European Headache Federation Congress 2019 - Abstracts

PRO questionnaires

Part 2 (N=2419)

1 PPTF (n=1034)

2 PPTF(n=690)

3 PPTF (n=324)

≥4 PPTF (n=371)

EQ-5D-5L utility index score

0.78 (0.22)

0.76 (0.22)

0.72 (0.24)

0.72 (0.22)

EQ VAS score

70.3 (19.85)

66.8 (20.07)

64.5 (20.31)

62.0 (20.94)

HIT-6 total score

64.6 (5.74)

65.1 (5.69)

66.4 (5.03)

66.3 (5.14)

MIDAS disability grade IV, n (%)

802 (77.6)

565 (81.9)

283 (87.3)

332 (89.5)

 

4–7 MMD(n=806)

8–14 MMD(n=605)

≥15 headache days/month, of which ≥8 are migraine days (n=1007)

EQ-5D-5L utility index score

0.82 (0.19)

0.81 (0.19)

0.68 (0.24)

EQ VAS score

73.7 (17.88)

72.6 (17.74)

59.0 (20.71)

HIT-6 total score

63.6 (5.89)

65.0 (5.41)

66.7 (5.04)

MIDAS disability grade IV, n (%)

583 (72.3)

492 (81.3)

907 (90.1)

  1. All values are mean (SD) unless otherwise indicated. EQ-5D-5L, EuroQol 5 dimensions 5 levels; HIT, Headache Impact Test; MIDAS, migraine disability assessment; MMD, monthly migraine days; N, total number of patients; n, number of patients; PPTF, prior prophylactic treatment failures; PRO, patient-reported outcomes; VAS, visual analogue scale